Centessa Pharmaceuticals (CNTA) Payables (2022 - 2025)
Historic Payables for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to $8.7 million.
- Centessa Pharmaceuticals' Payables rose 1665.99% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 1665.99%. This contributed to the annual value of $7.1 million for FY2024, which is 3954.3% down from last year.
- Per Centessa Pharmaceuticals' latest filing, its Payables stood at $8.7 million for Q3 2025, which was up 1665.99% from $5.7 million recorded in Q2 2025.
- In the past 5 years, Centessa Pharmaceuticals' Payables registered a high of $14.4 million during Q1 2023, and its lowest value of $5.1 million during Q1 2025.
- Moreover, its 4-year median value for Payables was $8.2 million (2022), whereas its average is $9.0 million.
- In the last 5 years, Centessa Pharmaceuticals' Payables surged by 11480.04% in 2023 and then crashed by 5200.72% in 2024.
- Centessa Pharmaceuticals' Payables (Quarter) stood at $13.8 million in 2022, then fell by 14.61% to $11.8 million in 2023, then plummeted by 39.54% to $7.1 million in 2024, then rose by 21.56% to $8.7 million in 2025.
- Its last three reported values are $8.7 million in Q3 2025, $5.7 million for Q2 2025, and $5.1 million during Q1 2025.